| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1026883999 |
| P356 | DOI | 10.1381/096089203321136539 |
| P698 | PubMed publication ID | 12630608 |
| P2093 | author name string | Bruno Geloneze | |
| Marcos A Tambascia | |||
| José C Pareja | |||
| Enrico M Repetto | |||
| Sylka R Geloneze | |||
| Victor F Pilla | |||
| P433 | issue | 1 | |
| P304 | page(s) | 17-22 | |
| P577 | publication date | 2003-02-01 | |
| P1433 | published in | Obesity Surgery | Q15762541 |
| P1476 | title | Ghrelin: a gut-brain hormone: effect of gastric bypass surgery | |
| P478 | volume | 13 |
| Q37938796 | A review of evidence-based strategies to treat obesity in adults |
| Q41585514 | An intragastric balloon produces large weight losses in the absence of a change in ghrelin or peptide YY. |
| Q48208868 | Appetite-regulating hormones from the upper gut: disrupted control of xenin and ghrelin in night workers |
| Q36533912 | Association of ghrelin receptor promoter polymorphisms with weight loss following Roux-en-Y gastric bypass surgery |
| Q38380271 | Bariatric embolization of the gastric arteries for the treatment of obesity |
| Q37930951 | Bariatric surgeries: beyond restriction and malabsorption |
| Q37736144 | Bariatric surgery and the gut hormone response |
| Q38055242 | Bariatric surgery, bone loss, obesity and possible mechanisms |
| Q35097848 | Breast milk hormones and regulation of glucose homeostasis |
| Q36970993 | Catalytic antibody degradation of ghrelin increases whole-body metabolic rate and reduces refeeding in fasting mice |
| Q37812028 | Changes in Ghrelin Levels Following Bariatric Surgery: Review of the Literature |
| Q30391329 | Changes in neurohormonal gut peptides following bariatric surgery |
| Q47189295 | Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass |
| Q47280174 | Characterization of weight loss and weight regain mechanisms after Roux-en-Y gastric bypass in rats |
| Q36479829 | Comparison of Bariatric Surgical Procedures for Diabetes Remission: Efficacy and Mechanisms |
| Q38663160 | Consequences of bariatric surgery on oesophageal function in health and disease |
| Q51488073 | Differential effects of gastric bypass and banding on circulating gut hormone and leptin levels. |
| Q36576963 | Drug insight: The functions of ghrelin and its potential as a multitherapeutic hormone |
| Q83222687 | Effect of gastric bypass on spontaneous growth hormone and ghrelin release profiles |
| Q33752066 | Effect of weight loss by diet or gastric bypass surgery on peptide YY3-36 levels |
| Q46779245 | Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release |
| Q51369049 | Effects of laparoscopic gastric band applications on plasma and fundic acylated ghrelin levels in morbidly obese patients. |
| Q43217775 | Effects of two variants of Roux-en-Y Gastric bypass on metabolism behaviour: focus on plasma ghrelin concentrations over a 2-year follow-up |
| Q37854918 | Endocrine factors in the hypothalamic regulation of food intake in females: a review of the physiological roles and interactions of ghrelin, leptin, thyroid hormones, oestrogen and insulin. |
| Q51458112 | Expression of ghrelin in fundus is increased after gastric banding in morbidly obese patients. |
| Q80424458 | Gastric/intestinal electrical stimulation modulates appetite regulatory peptide hormones in the stomach and duodenum in rats |
| Q34366918 | Gastrointestinal metabolic surgery for the treatment of type 2 diabetes mellitus |
| Q49463743 | Ghrelin and Obesity: Identifying Gaps and Dispelling Myths. A Reappraisal |
| Q36993604 | Ghrelin and feedback systems |
| Q34026487 | Ghrelin and metabolic surgery |
| Q37559829 | Ghrelin suppression is associated with weight loss and insulin action following gastric bypass surgery at 12 months in obese adults with type 2 diabetes |
| Q37113526 | Ghrelin: a new peptide regulating the neurohormonal system, energy homeostasis and glucose metabolism |
| Q35692577 | Ghrelin: integrative neuroendocrine peptide in health and disease |
| Q38357251 | Gut feedback mechanisms and food intake: a physiological approach to slow carbohydrate bioavailability |
| Q36616593 | Gut-brain neuropeptides in the regulation of ingestive behaviors and obesity |
| Q36810360 | Hypothalamic obesity in patients with craniopharyngioma: treatment approaches and the emerging role of gastric bypass surgery |
| Q36848440 | Impact of Weight Loss Surgery on Esophageal Physiology |
| Q47411049 | Impact of laparoscopic adjustable gastric banding on plasma ghrelin, eating behaviour and body weight |
| Q34981837 | Impact of sustained weight loss achieved through Roux-en-Y gastric bypass or a lifestyle intervention on ghrelin, obestatin, and ghrelin/obestatin ratio in morbidly obese patients |
| Q42627337 | Incretins: clinical physiology and bariatric surgery--correlating the entero-endocrine system and a potentially anti-dysmetabolic procedure |
| Q53832205 | Laparoscopic Gastric Bypass with Fundectomy and Gastric Remnant Exploration (LRYGBfse): Results at 5-Year Follow-up. |
| Q47247227 | Laparoscopic sleeve gastrectomy with ileal transposition (SGIT): A new surgical procedure as effective as gastric bypass for weight control in a porcine model. |
| Q90429528 | Leveraging the Gut to Treat Metabolic Disease |
| Q51491650 | Meal suppression of circulating ghrelin is normalized in obese individuals following gastric bypass surgery. |
| Q26780440 | Mechanism Underlying the Weight Loss and Complications of Roux-en-Y Gastric Bypass. Review |
| Q35529693 | Mechanisms responsible for excess weight loss after bariatric surgery |
| Q57116100 | Metabolic Surgery and Diabesity: a Systematic Review |
| Q37922651 | Metabolic surgery-principles and current concepts |
| Q36507088 | Obesity and the role of gut and adipose hormones in female reproduction |
| Q37511828 | Obesity, gut hormones, and bariatric surgery. |
| Q37000435 | Pathophysiology of obesity: why surgery remains the most effective treatment |
| Q47209015 | Persistent correlation of ghrelin plasma levels with body mass index both in stable weight conditions and during gastric-bypass-induced weight loss |
| Q90465272 | Rationale and Preclinical Data Supporting Bariatric Arterial Embolization |
| Q35963032 | Role of Gut-Related Peptides and Other Hormones in the Amelioration of Type 2 Diabetes after Roux-en-Y Gastric Bypass Surgery |
| Q37862878 | Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: understanding weight loss and improvements in type 2 diabetes after bariatric surgery. |
| Q44548921 | Serum ghrelin levels in response to glucose load in obese subjects post-gastric bypass surgery. |
| Q51528468 | Short-term effects of gastric bypass surgery on circulating ghrelin levels. |
| Q36801477 | Surgery for obesity: a review of the current state of the art and future directions |
| Q83170982 | Surgical treatment of obesity |
| Q42730636 | The Impact of Ghrelin in Metabolic Diseases: An Immune Perspective |
| Q37691662 | The effect of bariatric surgery on gut hormones that alter appetite |
| Q51280064 | Type 2 Diabetes Mellitus remission eighteen months after Roux-en-Y gastric bypass. |
| Q83852303 | WITHDRAWN: Ghrelin in obesity and endocrine diseases |
| Q47355415 | Weight Regain After Gastric Bypass: Influence of Gut Hormones |
| Q80197220 | [Factors associated with morbidity and mortality after gastric bypass. Alternatives for risk reduction: sleeve gastrectomy] |
| Q80502011 | [Laparoscopic reoperative sleeve gastrectomy] |
Search more.